Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe (PERISCOPE)

January 31, 2022 updated by: European Society of Anaesthesiology

Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe: Predicting Postoperative Pulmonary Complications in Europe: a 7-day Data Collection, Prospective, Observational Study

Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment.

Study Overview

Detailed Description

Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment.

Participating centres throughout Europe will contribute routine clinical data describing all eligible patients who undergo surgery during a continuous week (7-days) at convenience of every department within a period of two months from May 1st to July 1st 2011. A questionnaire of around 50 items will be filled during the pre, intra and postoperative periods. The follow-up will end at discharge. The aim of the PERISCOPE study is to validate a simple score to predict postoperative pulmonary complications(PPCs). This score has recently been published in Anesthesiology and you can access linking to: http://journals.lww.com/anesthesiology/Fulltext/2010/12000/Prediction_of_Postoperative_Pulmonary.20.aspx

TIMEFRAME Participants will be followed for the duration of in-hospital stay, an expected average of maximum 5 weeks.

Study Type

Observational

Enrollment (Actual)

5450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tirana, Albania
        • University Hospital centre "Mother Theresa" Anesthesia & critical Care
      • Brussels, Belgium, 1200
        • Cliniques Universitaires Saint Luc
      • Sarajevo, Bosnia and Herzegovina
        • General Hospital "Prim.dr Abdulah Nakas" Departement of Anaesthesia and intensive care
      • Sarajevo, Bosnia and Herzegovina
        • Heart Center
      • Rijeka, Croatia
        • University Hospital Rijeka Anaesthesiology and Intensive care
      • Brno, Czechia
        • Faculty Hospital Brno, department of Anaesthesiology and Intensive Care Medicine
      • Usti Nad Labem, Czechia
        • Masaryks hospital Usti nad labem, Dept. of Anesthesia and intensive medicine
      • Tartu, Estonia
        • Tartu University Hospital Clinic of Anaesthesiology and Intensive Care
      • Paris, France
        • Hôpital Pitié-Salpêtrière, Anesthesiology and Critical Care
      • Bonn, Germany
        • University Hospital Bonn, Anesthesiology
      • Darmstadt, Germany
        • Klinikum Darmstadt GmbH Anesthesiology, Intensive Care and pain medicin
      • Dresden, Germany
        • University Hospital Carl Gustav Carus, Dresden University of Technonology, Department of Anesthesiology and Intensive Care Therapy
      • Mainz, Germany
        • Universitätsmedizin Mainz, Departement of Anesthesiology
      • Miskolc, Hungary
        • MISEK Kft., Anaesthesiology and Intensive Care Unit
      • Bologna, Italy
        • S.Orsola-Malpighi
      • Cuneo, Italy
        • Azienda Ospedaliera S. Croce e Carle, Anesthesia
      • Genoa, Italy
        • Ospedale San Martino, Dipartimento di scienze chirurgiche e diagnostiche integrate
      • Milano, Italy
        • European Institute of Oncology,Anaesthesia and Intensive Care
      • Milano, Italy
        • University of Milano, Ospedale San Paolo Dpt Of Anaesthesia and Intensive Care
      • Padova, Italy
        • Azienda Ospedaliera Padova, Anesthesia and Intensive Care Clinic, Department of Pharmacology and Anesthesiology
      • Pontedera, Italy
        • Azienda USL n. 5 di Pisa Ospedale F. Lotti Anestesia e Rianimazione
      • Varese, Italy
        • University of Insubria
      • Riga, Latvia
        • P Stradins Clinical University hospital, Departement of Anesthesiology
      • Kaunas, Lithuania
        • Hospital of Lithuanian University of Health Sciences, Clinic of Anaesthesiology
      • Vilnius, Lithuania
        • Vilnius University Hospital Santariskiu Clinics, Center of Anesthesiology, Intensive Care and Pain Treatment
      • Luxembourg, Luxembourg
        • ZithaKlinik, Anaesthesiology and Intensive Care
      • Bydgoszcz, Poland
        • 10 Wojskowy Szpital Kliniczny z Polikliniką w Bydgoszczy, Anaesthesiology and Intensive Care
      • Coimbra, Portugal
        • Hospitais da Universidade de Coimbra, EPE. Departement of Anesthesiology
      • Lisbon, Portugal
        • Centro Hospitalar de Lisboa Ocidental, Serviço de Anestesia
      • Lisbon, Portugal
        • Hospital Fernando Fonseca,Anesthesiology
      • Porto, Portugal
        • Instituto Português de Oncologia, Departement of Anesthesiology
      • Bucharest, Romania
        • Emergency Institute of Cardiovascular Diseases Prof Dr C. C. Iliescu, Cardiac Anesthesia and Intensive Care
      • Constanta, Romania
        • Emergency Clinical Hospital of Constanta, Department of Anaesthesiology and Intensive Care
      • Târgu-Mureş, Romania
        • Emergency County Hospital Clinic of Anesthesia and Intensive Care, Intensive Care and Anesthesiology
      • Krasnoyarsk, Russian Federation
        • Krasnoyarsk State Medical University,Anesthesiology and Intensive Care
      • Alicante, Spain
        • Hospital General Universitario Alicante, Anaesthesiology
      • Badalona, Spain
        • Hospital Universitari Germans Trias i Pujol, Anaesthesiology
      • Barcelona, Spain
        • Corporació Sanitària Parc Taulí, Anaesthesiology
      • Barcelona, Spain
        • Fundació Puigvert Anaesthesiology
      • Barcelona, Spain
        • Hospital Clinic, Anaesthesiology
      • Barcelona, Spain
        • Hospital Sant Pau, Anaesthesiology
      • Barcelona, Spain
        • Parc de Salut Mar, Anesthesiology
      • Barcelona, Spain
        • Vall d'Hebron University Hospital, Anaesthesiology
      • Breña Alta, Spain
        • Hospital General de La Palma, Anestesiología y Reanimación
      • Denia, Spain
        • Hospital de Denia,Anesthesia and Intensive Care
      • Huesca, Spain
        • Hospital San Jorge, Anaesthesiology
      • Lleida, Spain
        • Hospital Arnau de Vilanova Departement of Anesthesiology
      • Lleida, Spain
        • Hospital Santa Maria, Departement of Anesthesiology
      • Madrid, Spain
        • Hospital 12 Octubre, Anaesthesiology
      • Madrid, Spain
        • Hospital del Tajo Anaesthesia and Reanimation
      • Madrid, Spain
        • Hospital Universitario de La Princesa, Anesthesiology
      • Madrid, Spain
        • Hospital Universitario de Móstoles, anestesiología y Reanimación
      • Manresa, Spain
        • Fundacio Althaia, Anaesthesiology
      • Palma de Mallorca, Spain
        • Hospital Son Llatzer, Anaesthesiology
      • Pamplona, Spain
        • Clinica Universidad de Navarra, Anaesthesia
      • Santander, Spain
        • Hospital Universitario Marques de Valdecilla
      • Seville, Spain
        • Virgen del Rocio General Universitary Hospital;Anaesthesiology
      • Valencia, Spain
        • Consorcio Hospital General Universitario, Anesthesiology, Critical Care and Pain Relief Unit
      • Valencia, Spain
        • Hospital Clínic Universitari de València, Anestesiología y Reanimación
      • Valladolid, Spain
        • Hospital Universitario Rio Hortgea, Anaesthesia and Surgical Critical Care
      • Lugano, Switzerland
        • Ospedale Regionale di Lugano, Anestesia
      • Istanbul, Turkey
        • Medical Faculty of Istanbul, Istanbul University, Anaesthesiology
      • Odessa, Ukraine
        • St.Katherine Hospital of Cardiology Anesthesiology & Pain Treatment

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In-patient adult non-obstetric surgery

Description

Inclusion Criteria:

Patients undergoing a non-obstetric in-hospital surgical procedure, elective or emergent, under general anaesthesia (alone or in combination with regional/neuraxial anaesthesia), neuraxial anaesthesia or plexus block (with and without sedation).

Exclusion Criteria:

  1. age <18 years
  2. obstetric procedures or any procedure during pregnancy
  3. regional anaesthesia alone, except to neuroaxial and plexus anaesthesia
  4. procedures outside the operating room
  5. procedures related to a previous postoperative complication
  6. transplantation
  7. patients with preoperatively intubated trachea
  8. outpatient procedures, defined as those requiring less than one day's stay for a patient alive at discharge.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
In-patient Adult Non-obstetricSurgical

Consecutive patients admitted to participating centres undergoing surgery Non-obstetric in-hospital surgical procedure, elective or emergent, under general anaesthesia (alone or in combination with regional/neuraxial anaesthesia), neuraxial anaesthesia or plexus block (with and without sedation).

All eligible patients undergoing surgery within the seven day study period will be recruited wherever possible.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Main Outcome, Defined as a Postoperative Pulmonary Complications (PPC), Will be a Composite of the In-hospital Fatal or Non-fatal Postoperative Events.
Time Frame: Postoperative in-hospital stay up to 5 weeks
Will include:Mild respiratory failure;Severe respiratory failure;acute lung injury(ALI)/Acute respiratory distress syndrome(ARDS);Suspected pulmonary infection;Pulmonary infiltrate;Pleural effusion;Atelectasis;Pneumothorax;Bronchospasm;Aspiration Pneumonitis;Cardiopulmonary edema.Investigators will not modify centre usual patient management. Patients with PPCs will identify by consulting medical records and looking for events fulfilling PPCdefinition. Diagnosis date for every complication will be recorded.Participants will be followed during in-hospital stay up to 5 weeks.
Postoperative in-hospital stay up to 5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
a) Postoperative Length of Stay
Time Frame: Postoperative in-hospital stay up to 90 days
Participants will be followed for the duration of in-hospital stay up to 90 days
Postoperative in-hospital stay up to 90 days
b) In-hospital Mortality
Time Frame: Postoperative in-hospital stay up to 90 days
Participants will be followed for the duration of in-hospital stay up to 90 days
Postoperative in-hospital stay up to 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jaume Canet, MD, Hospital Universitari Germans Trias I Pujol, Barcelona, Spain
  • Principal Investigator: Sergi Sabaté, MD, PhD, Fundació Puigvert (IUNA), Barcelona, Spain
  • Principal Investigator: Olivier Langeron, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
  • Principal Investigator: Marcelo Gama de Abreu, MD,PhD,DEAA, University Hospital Carl Gustav Carus Dresden University of Technology, Dresden, Germany
  • Principal Investigator: Lluís Gallart, MD, Parc de Salut Mar Anaesthesiology Research Group IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain
  • Principal Investigator: Francisco Javier Belda, MD, Hospital Clínico Universitario de Valencia, Valencia, Spain
  • Principal Investigator: Paolo Pelosi, MD, PhD, University of Genoa, Genoa, Italy - San Martino Hospital, Genoa, Italy
  • Study Chair: Valentin Mazo, MD, Hospital Universitari Germans Trias I Pujol, Barcelona, Spain
  • Principal Investigator: Andreas Hoeft, MD, University Hospital, Bonn

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

September 1, 2011

Study Registration Dates

First Submitted

April 20, 2011

First Submitted That Met QC Criteria

May 2, 2011

First Posted (Estimate)

May 3, 2011

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

January 31, 2022

Last Verified

October 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complication of Surgical Procedure

3
Subscribe